Evala Nerve Stimulator (EPNR002)— 510(k) K253536

Substantially Equivalent

Epineuron Technologies, Inc.

FDA 510(k) clearance K253536 for Evala Nerve Stimulator (EPNR002), Substantially Equivalent on 2026-02-27. Applicant: Epineuron Technologies, Inc.. Device class: 2.

Summary

Epineuron Technologies filed the Evala Nerve Stimulator (EPNR002) under product code ETN (Stimulator, Nerve). The record gives no further description of the device.

Class II, 21 CFR 874.1820. Ear, Nose, Throat is both the classification panel and the review panel, and it came in as a Traditional 510(k).

Epineuron Technologies filed from Mississauga, Canada. The decision came 106 calendar days after FDA received it (November 13, 2025 to February 27, 2026), and it was substantially equivalent.

Clearance details

Applicant
Epineuron Technologies, Inc.
Product code
Product code ETN
Device class
Class 2
Regulation
21 CFR 874.1820
Advisory panel
Ear, Nose, Throat
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Mississauga, CA
Download summary PDFView on FDA.gov ↗

Recent devices under product code ETN

view all

Adverse events under product code ETN

product code ETN
Death
7
Injury
327
Malfunction
2,776
Total
3,110

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.